Stockscreener 앱 받기
1.18
4.42%
0.05
전일 마감가:
$1.13
열려 있는:
$1.15
하루 거래량:
251.94K
Relative Volume:
0.70
시가총액:
$25.45M
수익:
-
순이익/손실:
$-8.29M
주가수익비율:
-1.6857
EPS:
-0.7
순현금흐름:
$-6.47M
1주 성능:
+5.36%
1개월 성능:
-8.53%
6개월 성능:
-26.25%
1년 성능:
-1.67%
1일 변동 폭
$1.14
$1.20
1주일 범위
$1.11
$1.235
52주 변동 폭
$0.94
$2.2299
NanoViricides Inc Stock (NNVC) Company Profile
명칭
NanoViricides Inc
전화
203-937-6137
주소
1 Controls Drive, Shelton, CT
NNVC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NNVC
NanoViricides Inc
|
1.18 | 24.37M | 0 | -8.29M | -6.47M | -0.70 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
NanoViricides Inc Stock (NNVC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-16 | 개시 | Alliance Global Partners | Buy |
| 2015-02-11 | 개시 | Midtown Partners | Strong Buy |
NanoViricides Inc 주식(NNVC)의 최신 뉴스
Aug Momentum: Is NanoViricides Inc forming a bullish divergenceTrade Analysis Summary & Risk Adjusted Buy/Sell Alerts - baoquankhu1.vn
NanoViricides Comments on the Need for Broad-Spectrum Antivirals in Light of the Current Influenza WaveNV-387 is Effective Against H3N2 - Lebanon Daily News
Support Test: Should I invest in NanoViricides Inc before earningsJuly 2025 PostEarnings & Free Fast Gain Swing Trade Alerts - baoquankhu1.vn
Jobs Data: How much upside does NanoViricides Inc have2025 Bull vs Bear & Long-Term Capital Growth Strategies - baoquankhu1.vn
NanoViricides Highlights Need for Broad-Spectrum Antivirals During Severe Influenza Season - citybuzz -
NanoViricides highlights need for broad-spectrum antivirals amid severe flu season - Proactive financial news
San Gabriel Valley Tribune - FinancialContent
Options Flow: Will NanoViricides Inc. stock continue dividend increases2025 Winners & Losers & Short-Term Swing Trade Alerts - Bộ Nội Vụ
Market Recap: Can NanoViricides Inc NV3P stock sustain institutional flowsInflation Watch & Stock Portfolio Risk Control - Bộ Nội Vụ
After-Hours Rally: Zentalis, LifeMD, And NanoViricides Among Top Gainers - Nasdaq
Published on: 2026-01-10 19:47:32 - ulpravda.ru
Volume Summary: Will NanoViricides Inc NV3P stock outperform small cap peersJuly 2025 Chart Watch & Reliable Breakout Forecasts - moha.gov.vn
NanoViricides Has Received Approval to Start Phase II Clinical Trial of NV-387 for the Treatment of MPox by the Regulatory Agency ACOREP of the Democratic Republic of Congo - The Patriot Ledger
Can NanoViricides Inc. stock outperform in 2025 bull marketJuly 2025 Weekly Recap & Reliable Price Action Trade Plans - Улправда
Can NanoViricides Inc. stock hit record highs againPortfolio Update Summary & Expert Curated Trade Setup Alerts - Улправда
NanoViricides Announces Closing of $6 Million Registered Direct Offering and Concurrent Private Placement Priced at the Market Close - Times Record News
Geopolitics Watch: How analysts rate NanoViricides Inc. stock todayInflation Watch & Fast Moving Stock Trade Plans - Улправда
Inflation Data: How SUNE stock reacts to inflationary pressuresJuly 2025 Summary & Verified Technical Trade Signals - moha.gov.vn
Can NanoViricides Inc. stock sustain market leadershipJuly 2025 Market Mood & Weekly Consistent Profit Watchlists - Улправда
How risky is NanoViricides Inc. stock nowJuly 2025 Snapshot & Advanced Swing Trade Entry Alerts - Улправда
Market Review: Is NanoViricides Inc. stock oversold or undervaluedQuarterly Trade Report & Low Drawdown Trading Strategies - Улправда
How analysts rate NanoViricides Inc. stock todayQuarterly Profit Report & Weekly Stock Breakout Alerts - Улправда
Can NanoViricides Inc. stock weather global recessionBull Run & Daily Profit Focused Screening - ulpravda.ru
NanoViricides, Inc. Has Filed its Quarterly ReportSubsequent Raise Has Fortified Fiscal Position - Fall River Herald News
Is NanoViricides Inc stock oversold or undervaluedMarket Growth Review & Reliable Entry Point Trade Alerts - Bộ Nội Vụ
Profit Recap: How risky is NanoViricides Inc stock nowJuly 2025 PreEarnings & Consistent Profit Alerts - Bộ Nội Vụ
NanoViricides to Present at the Spartan Capital Investor Conference 2025 in New York City Today, November 3rd - thespectrum.com
NanoViricides Announces Pricing of $6 Million Registered Direct Offering and Concurrent Private Placement Priced at the Market Close - The Coloradoan
NanoViricides to Present at the PODD 2025 Conference in Boston on October 27 - The Register-Guard
NanoViricides Has Signed a Master Services Agreement with OnlyOrphansCote Regarding Orphan Drug Strategy of NV-387 for Treatment of MPox, Smallpox, and Measles - Fall River Herald News
Treating Measles Infection: Nanoviricides CEO Dr Anil Diwan Interviewed by Steve Darling from Proactive - The Register-Guard
Hogs Drift in a Quiet Session - Barchart.com
Cotton Faces Pressure into the Close - Barchart.com
Wild Yangtze: Echoes of Life from the River’s Rare Species - Barchart.com
Stocks slip on Wall Street as 2025 winds down - Barchart.com
QuantumScape Gained 100% in 2025 and Is Set to Generate Revenue for the First Time in 2025. Options Data Suggests You Should Play QS Stock Like This for 2026. - Barchart.com
MongoDB, AppLovin, and SoundHound AI Stocks Trade Down, What You Need To Know - Barchart.com
Why RXO (RXO) Stock Is Down Today - Barchart.com
Alibaba Was the Market’s Favorite Chinese AI Stock in 2025: What’s BABA’s 2026 Forecast? - Barchart.com
After Long Preparation, Sun Star Roofing Begins Serving the Pittsburgh Area with a Comprehensive Exterior Vision - Barchart.com
Cotton Holding onto Slight Gains on Monday - Barchart.com
Short Sellers Are Betting Against Lumentum Stock. Will They Be Proven Right? - Barchart.com
Hogs Fall to Weakness on Friday - Barchart.com
2 S&P 500 Stocks to Target This Week and 1 We Brush Off - Barchart.com
2 Reasons to Watch PYPL and 1 to Stay Cautious - Barchart.com
New Year, Even Better Liquidity for Brokers in 2026 - Barchart.com
Netflix Is Out of Favor—and That’s Why It’s Getting Interesting - Barchart.com
A Systematic Exploration of Technological Risks: Hu Jiaqi’s Foresight and Practice - Barchart.com
Sidus Space Announces Pricing of Offering - Barchart.com
NanoViricides Inc (NNVC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.73%
0.92%
자본화:
|
볼륨(24시간):